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Abstract
Background: The recent discovery of widespread copy number variation in humans has forced a
shift away from the assumption of two copies per locus per cell throughout the autosomal genome.
In particular, a SNP site can no longer always be accurately assigned one of three genotypes in an
individual. In the presence of copy number variability, the individual may theoretically harbor any
number of copies of each of the two SNP alleles.
Results: To address this issue, we have developed a method to infer a "generalized genotype" from
raw SNP microarray data. Here we apply our approach to data from 48 individuals and uncover
thousands of aberrant SNPs, most in regions that were previously unreported as copy number
variants. We show that our allele-specific copy numbers follow Mendelian inheritance patterns that
would be obscured in the absence of SNP allele information. The interplay between duplication and
point mutation in our data shed light on the relative frequencies of these events in human history,
showing that at least some of the duplication events were recurrent.
Conclusion: This new multi-allelic view of SNPs has a complicated role in disease association
studies, and further work will be necessary in order to accurately assess its importance. Software
to perform generalized genotyping from SNP array data is freely available online [1].
Background
A copy number variant (CNV) is defined as a chromo-
somal segment, at least 1 kb in length, whose (germline)
copy number varies across individuals in the human pop-
ulation [2]. As the importance of these duplications and
deletions in the study of a variety of diseases [3-6] is being
realized, cataloging them and assessing their frequencies
has become an important goal. Toward this end, two
recent studies [7,8] have exploited erroneous SNP geno-
type calls, inferring germline deletions at clusters of calls
that violate Mendelian inheritance or other conditions.
The violations occur, however, as a result of the (diallelic)
assumption of three possible genotypes (e.g. GG, GT, or
TT) at each SNP site. If this assumption of two copies at
each locus were relaxed, one could consider a generalized
genotype whereby the SNP is multi-allelic when consider-
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ing both base residue and copy number. An individual
could carry, for example, a GGT (duplication), G –
(hemizygous deletion), or – (homozygous deletion) gen-
otype at a SNP locus. As most recent estimates put the pro-
portion of the genome harboring CNVs at at least 12%
[9], allowing for more general genotypes is crucial for the
accuracy of SNP typing in disease studies. Such direct and
accurate typing would, of course, reveal CNVs automati-
cally.
The GeneChip Human Mapping Array Set [10] is a popu-
lar platform for high throughput SNP genotyping. We use
data from the version of the platform – herein referred to
as the SNP array – that interrogates over 500,000 SNP
sites. Since 85% of the genome is within 10 kb of at least
one SNP on the array [10], many of the duplications and
deletions of the size that have been reported thus far
should contain several of the SNP sites represented on the
array. Indeed, 58,353 of its 490,032 autosomal SNPs are
contained in at least one of the CNVs that have been
reported in the literature to date and catalogued in the
Database of Genomic Variants [11]. In an earlier study
[12] we utilized the array data to detect, in an allele-spe-
cific manner, somatic copy number changes in cancer
samples, also demonstrating an extremely high genotyp-
ing accuracy (> 99.7%) in the diallelic setting. We there-
fore endeavored in the present study to adapt this
approach to SNP array data from "phenotypically nor-
mal" individuals in an effort to provide a generalized gen-
otype, allowing for germline CNVs as described above.
The approach is somewhat akin to array CGH [13] meth-
ods to detect CNVs, but with at least two advantages. First,
it is difficult in array CGH analysis to determine whether
an apparent deviation from copy number two is the result
of a CNV in the test sample or in the reference sample. In
our approach, we exploit a large reference panel of indi-
viduals, ensuring that the reference signal is essentially
two-copy, except potentially in regions with very common
CNVs. Second, while the array CGH platforms lack allele-
specific information, the SNP array is comprised of oligo-
nucleotide probes that can distinguish between each of
the two alleles of each SNP. Our method models these
probes' intensities as a function of allele-specific copy
number, which directly determines the generalized geno-
type. The copy numbers are inferred from the SNP array
data by applying statistical model-fitting procedures.
Results and discussion
Detected aberrations
We analyzed SNP array data from a collection of 48 indi-
viduals of various ethnic backgrounds. For a reference
panel, we used 16 unrelated individuals of African, Afri-
can-American, Asian, European, and Hispanic ethnicities
(see Methods). An ethnically diverse panel of reference
samples minimizes the likelihood of a recurrent CNV
skewing the "copy number two" reference signal. Apply-
ing our algorithm to all automsomal SNPs on the array,
we found 21,568 SNP loci that demonstrated aberrant
genotypes (Additional data file 1). Of these, 17,390 were
detected as duplications (total copy number > 2), 5,051 as
hemizygous deletions (total copy number 1), and 214 as
homozygous deletions (total copy number 0). There were
881 sites that were detected as both duplications and dele-
tions. The 21,568 SNPs can be grouped into 5,622 regions
of consecutive duplicated SNPs and 1,130 regions of con-
secutive deleted SNPs Regarding recurrence, 3,721
(17.3%) SNPs were aberrant in more than one individual
(Figure 1a), with one SNP (rs1842908) showing a non-
diploid genotype in 24 of the 48 individuals.
Experimental validation
In order to validate our discoveries using independent
experimental means, we performed quantitative real-time
PCR (qPCR) experiments for 30 of the regions containing
putatively aberrant SNPs, using DNA from individuals in
our sample set. A comparison of the qPCR results with our
genotype inferences is given in Table 1. Overall, 26
Frequencies of aberrant SNPs in our study Figure 1
Frequencies of aberrant SNPs in our study. For each 
SNP, the number of samples aberrant at that locus was 
counted. We constructed histograms of frequencies for 
SNPs that were aberrant in more than one sample. (a) For 
each count c on the horizontal axis, the height of the bar 
indicates the number of SNPs that were aberrant in c sam-
ples out of 48. (b) Same as a, but with all trio offspring 
removed so that only 35 unrelated samples are considered.
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(86.7%) of the qPCR results agreed with the presence and
type (duplication or deletion) of CNV predicted by our in
silico approach. There are a variety of potential reasons for
the four nonconcordant loci. Since the PCR primers are
explicitly designed to avoid the SNP sites (yet be near the
aberrant SNPs), and since CNVs can be quite focal, it is
possible for the PCR-amplified region to miss the aberrant
locus entirely. A detected deletion could also be an artifact
of the SNP array assay, since the deletion or duplication
elsewhere in the restriction fragment may result in its
length moving outside the range of lengths that the assay's
PCR step would amplify [10]. As mentioned above, com-
mon CNVs in the human population are another poten-
tial source of error, since it is implicitly assumed that the
reference panel primarily harbors two copies per cell at
each locus. To provide further independent validation, we
also performed multiplex ligation-dependent probe
amplification (MLPA) [14] experiments on 17 other puta-
tive CNVs (Figure 2 and Additional data file 2). The con-
cordance with the in silico genotypes was similar to that of
the qPCR results.
Mendelian inheritance considerations
It is well-established [9,15,16] that there are genomic
regions harboring germline CNVs in the form of both
duplications and deletions in different individuals.
Indeed, the non-allelic homologous recombination
model of the formation of the variants generates both
duplications and deletions, simultaneously at the same
locus. It follows that, as these variants segregate through
the population, there will be individuals carrying both a
gain and a loss at the same locus, though on different
parental chromosomes. The observable patterns of Men-
delian inheritance in the aberrant genotype setting are dif-
ferent from those in diallelic SNP genotyping or even in
aggregate copy number measurement, and ignoring the
presence of CNVs can result in the false appearance of
non-Mendelian inheritance as a result of genotyping
errors (Figure 3a and Additional data file 3). Truly non-
Mendelian inheritance, e.g. de novo events (Figure 3b and
Additional data file 3) can be masked as well. These errors
will also occur when only aggregate copy number is meas-
ured but allelic information is ignored. Misinterpreting
Table 1: Comparison of in silico and in vitro results for 30 putatively aberrant SNPs. Here, the diploid genotype refers to that provided 
by the SNP array's default software [24], under the assumption of two copies of the SNP. The errors shown are typical in the presence 
of CNVs. The aberrant genotype here is our algorithm's call. We consider the putative CNV to be validated if the rounded qPCR copy 
number is less than 2 (for deletions) or greater than 2 (for duplications).
Sample rs ID Diploid genotype Aberrant genotype Frequency (unrelated samples) qPCR copy number Validated?
NA10851 rs17525374 GG G - 1 1.17 Yes
NA10851 rs9542207 TT T - 1 0.86 Yes
NA10851 rs6601728 GG G - 1 1.40 Yes
NA10851 rs17133566 CC C - 1 0.98 Yes
NA10863 rs5751296 CT CTT 1 2.74 Yes
NA10863 rs17577094 TT TTT 5 4.27 Yes
NA12707 rs1565516 GG G - 1 1.95 No
NA12707 rs2013317 GG GGG 4 6.14 Yes
NA12801 rs2304717 CC CCC 1 4.29 Yes
NA12801 rs12697975 CC C - 1 0.84 Yes
NA12801 rs2889833 GG G - 1 1.24 Yes
NA10851 rs11780672 AA A - 1 0.76 Yes
NA10863 rs3828886 AA AAA 8 2.12 No
NA10863 rs3858489 AG AGG 5 3.40 Yes
NA10863 rs17662235 TT TTT 7 3.36 Yes
NA10863 rs6994627 AA A - 1 0.88 Yes
NA10863 rs2604357 GG G - 1 1.54 No
NA10863 rs10110189 CC C - 1 0.85 Yes
NA10863 rs2721243 CC C - 1 1.01 Yes
NA10863 rs737714 No Call A - 1 0.00 Yes
NA10863 rs7833963 AA A - 1 1.05 Yes
NA10863 rs4831667 AA A - 1 0.82 Yes
NA10863 rs7464441 AA A - 1 1.36 Yes
NA12707 rs1018685 AA AAA 1 1.59 No
NA12707 rs16993280 No Call - - 3 0.00 Yes
NA12707 rs361901 AA A - 4 1.40 Yes
NA12707 rs12170791 CC C - 2 0.98 Yes
NA12707 rs2532292 AA AAA 7 4.51 Yes
NA12707 rs2732675 No Call TTT 10 2.53 Yes
NA12707 rs4822622 CC C - 1 1.06 YesBMC Genomics 2007, 8:211 http://www.biomedcentral.com/1471-2164/8/211
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germline CNVs as de novo, or vice versa, can have important
implications, particularly in clinical settings where such
variants in an affected individual are considered less rele-
vant when inherited from an unaffected parent [17]. With
multi-allelic SNP genotypes, we should be able to distin-
guish between the two cases. We were able to check aber-
rant SNPs for Mendelian inheritance in the 13 mother-
father-child trios in our data set. Accounting for both SNP
and copy number variation, 1,535 of the 1,771 instances
of putatively aberrant SNPs in the four individuals
(86.7%) demonstrated Mendelian inheritance. Possible
explanations for non-Mendelian events include de novo
CNVs or uniparental disomy, both of which have been
detected using the SNP array platform [18-20]. Alterna-
tively, detected CNVs may be instead artifacts of cell line
culture, as observed in [9].
SNP alleles in duplications
Examination of the SNP allelic composition of duplicated
regions can provide insight into the history of copy
number variation in the human population. In the case of
a SNP site that is duplicated with (haploid) copy number
two, there are theoretically five possible haploid geno-
types for that SNP: AA, AB, BB, A, and B, where A and B are
the two base residues for the SNP site. The presence or
absence of each of these five haploid genotypes sheds
light on recurrence and temporal order of both the dupli-
cation event at that locus as well as the point mutation
that resulted in the SNP. For example, the presence of
both AA and BB would imply a recurrent duplication,
occurring on both the A and B SNP background. To inves-
tigate empirically, we examined 496 aberrant loci in detail
(see Methods). We found no evidence of a single chromo-
some with different base residues on each copy of a dupli-
cation (i.e. an AB chromosome) (Figure 4a). It is therefore
unlikely that the "SNP in duplicon" phenomenon noted
recently [21] for segmental duplications is common in
CNVs. This is also consistent with the conclusion of the
HapMap consortium [22] that the point mutations lead-
ing to SNPs are largely non-recurrent. In the vast majority
of cases, only one of the SNP alleles was duplicated in our
sample set. Still, six (1.2%) of the SNP sites had evidence
Mendelian and non-Mendelian inheritance patterns in the  presence of CNVs Figure 3
Mendelian and non-Mendelian inheritance patterns in 
the presence of CNVs. (a) Although the parent on the left 
has copy number two at the locus, this is the result of a 
duplication on one chromsome and a deletion on the other. 
Standard (diallelic) genotyping methods would incorrectly 
identify a non-Mendelian pattern at the locus in this trio, as 
would total copy number information alone. However, accu-
rate genotyping, taking CNVs into account, reveals that the 
pattern is Mendelian. (b) The de novo deletion is obscured 
when diallelic genotyping alone is considered, though copy 
number information reveals the event.
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array data or experimental difficulties for that particluar sam-
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of both AA and BB chromosomes. The presence of both
types show that at least some duplication events were
most likely recurrent in human history (alternative expla-
nations seem unlikely, particularly given the complete
absence of evidence for any AB chromosomes). An exam-
ple is rs7895458 on chromosome 10 (Figure 4b), which is
contained in a previously known recurrently duplicated
region [9]. In our data set, one Caucasian family –
NA12056 (father) and NA10851 (child) – harbors the
duplication with the C allele at the SNP in both copies.
Japanese individual NA18959, on the other hand, harbors
the duplication with the G allele at the SNP in both cop-
ies. Interestingly, the dbSNP database [23] lists the allele
frequency for C as 65% in the Caucasian population, but
only 15% for the Japanese population. These duplications
were observed independently in [9] in all three of these
individuals, though the SNP allelic information was
ignored in that study. Similarly, the SNP array manufac-
turer's [24] diallelic calls, CC for NA10851 and GG for
NA18959, were erroneous though consistent with what
was expected given their two-copy assumption. This
example points to the insights that can be gained from
consideration of both copy number and SNP residue
simultaneously.
Comparison with previous work
Since our detected aberrant SNPs automatically indicate
the presence of CNVs, we compared the genomic coordi-
nates of these loci to CNVs previously reported in the lit-
erature. Of our 21,568 SNP loci, 5537 (25.7%) are
contained in regions catalogued as CNVs in the Database
of Genomic Variants, while only 11.9% of the 490,032
autosomal SNPs on the SNP array are contained in these
regions. Though this demonstrates more overlap than
would be expected by chance, the majority of loci we have
uncovered are novel. However, one would expect that
recurrently variant SNPs in our data set would often exist
at a higher frequency in the general population, and
Interplay between duplication status and SNP allele Figure 4
Interplay between duplication status and SNP allele. (a) Of 496 interrogated duplication loci, we observed 6 cases 
(1.2%) with both AA and BB chromosomes, and none with AB chromosomes. When only one SNP allele was unambiguously 
duplicated, 92.5% of the time it was the major allele in our sample set. (b). An example of a Caucasian trio and a Japanese indi-
vidual harboring different SNP alleles in the duplicon.
a )            b )
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would thus be more likely to have been previously discov-
ered. Indeed, if we restrict our attention to SNPs that are
aberrant in at least two unrelated individuals in our sam-
ple set, we find that 1062 of 1905 (55.7%) of these lie in
previously reported CNVs. As the aberrance rate of a SNP
in our sample increases, its likelihood of having been pre-
viously reported continues to rise – over 95% of the 351
SNPs that are aberrant in at least 10% of our unrelated
sample set are contained in previously reported CNVs.
Therefore, although we report thousands of new CNVs,
our results are in some sense concordant with what has
been revealed on a population level. Since it has been
shown that sequence between intrachromosomal seg-
mental duplications are predisposed to CNVs [25], we
also checked for enrichment of these "hotspots" [16] in
our set of CNVs. Only 2,336 (10.8%) of our aberrant SNP
loci were contained in these regions reported in the Struc-
tural Variation Database, which is only a slightly higher
proportion than that of all autosomal SNPs on the array
(8.1%).
Genes in regions of copy number variation
Many genes previously confirmed as polymorphic have
functions in metabolism and immunity, and likely act as
mediators of normal human variation as well as genomic
disease. We compiled a list of transcribed CNVs in our
data, along with the Gene Ontology [26] (GO) terms that
were associated to these transcripts. We examined our list
for GO terms that were present at a statistically higher rate
compared to all genes containing SNPs represented on the
array (see Methods). This allowed the identification of
several interesting categories of genes involved in cell sur-
face structure, glutamate metabolism and signaling, and
genes with metabolic, enzymatic and neurological func-
tions. In concordance with previous studies, we con-
firmed the presence of CNVs in genes such as DUSP22,
NCAM2 [27], and NF1 [16]. Also present in our list are
genes that are known to influence "normal" human phe-
notypes, such as the copy number-polymorphic olfactory
receptor genes [28], and the neuropeptide-Y4 receptor
PPYR1 [27] that is directly involved in the regulation of
food intake and body weight [29]. A number of "environ-
mental sensor" genes involved in immune system
response were also observed, in categories such as granu-
locyte differentiation, receptor-mediated endocytosis,
antibiotic response, regulation of IgG/IgE isotype switch-
ing, regulation of NK cell activity, IL-4 receptor binding
and MHC class 1 receptor activity. In addition, a large pro-
portion of the CNV-enriched classes have receptor and/or
signaling functions. It is important to note that a number
of genes previously reported to be copy number variant,
such as the glutathione S-transferase genes GSTM1 and
GSTT1, are not represented on the SNP array, perhaps due
to the fact that they would give ambiguous genotype calls.
Conclusion
We have presented the first computational method for
genotyping SNPs from microarray data in the general case
where the individual is not restricted to two copies of the
SNP locus per cell. Our work highlights, with several
examples, the relevance of considering both copy number
and SNP allelic information simultaneously. We have
uncovered tens of thousands of SNPs with aberrant geno-
types in humans of various ethnicities, corresponding to
thousands of novel CNVs. It is likely that our results actu-
ally drastically underrepresent the prevalence of aberrant
SNPs in the population, as the array's manufacturer delib-
erately excluded SNPs that violated Hardy-Weinberg equi-
librium, Mendelian inheritance, and other quality control
requirements [10] that would naturally not be met in the
presence of CNVs. Moreover, our own requirement that at
least three consecutive SNPs show the CNV is very con-
servative, and will by definition omit more focal events
(in practice, our method can be tuned in this way to con-
trol the false positive/false negative tradeoff, as desired). It
follows that the number and frequency of these multi-
allelic SNPs segregating through the population is likely
to be much more substantial than previously suspected,
and therefore generalized genotyping of the sort we have
described here is crucial in studies using SNPs as markers.
Our work is a step in that direction, though the goal
should be to attain the high rates of accuracy (> 99%) that
are assumed in the diallelic setting. Such highly accurate
genotyping would automatically provide information
regarding the presence or absence of CNVs. Given the dif-
ficulty in precisely mapping the boundaries of these germ-
line CNVs (with recent evidence that the boundaries
actually differ between individuals in the population
[30]), and given the density of SNPs on the genome, we
propose aberrant SNP genotyping as an alternative to
other methods of categorizing CNVs from SNP array data
[31]. Such genotypes map to precise genomic locations,
and provide information on both copy number and base
residue. The resulting multi-allelicism will be an aid to
disease association studies, whether these more accurately
ascertained SNP alleles are actually causal inherited vari-
ants, or are simply used as markers. Since there are many
thousands of SNP array samples extant, these multi-allelic
SNPs segregating through the population will be identi-
fied and their frequencies ascertained. We have developed
software, freely available at our web site, with which users
can scan their arrays for aberrant SNPs, using reference
panels of their choice. As the platforms increase in
throughput and decrease in cost, accurate multi-allelic
genotyping will be even more crucial.
Methods
SNP array data and biological samples
The raw .cel files from the 48 individuals – NA10851,
NA10855, NA10863, NA11831, NA11832, NA12056,BMC Genomics 2007, 8:211 http://www.biomedcentral.com/1471-2164/8/211
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NA12057, NA12234, NA12264, NA12707, NA12716,
NA12717, NA12801, NA12812, NA12813, NA18503,
NA18504, NA18505, NA18506, NA18507, NA18508,
NA18515, NA18516, NA18517, NA18532, NA18545,
NA18558, NA18605, NA18612, NA18959, NA18967,
NA18969, NA18997, NA19137, NA19138, NA19139,
NA19152, NA19153, NA19154, NE00088, NE00090,
NE00091, NE00375, NE00403, NE00598, NE00963,
NE01118, and NE01119 – in the Mapping 500 K Sample
Data Set were downloaded from the Affymetrix web site
[32]. These individuals are of African (15), European
American (15), Han Chinese (5), Japanese (4), African
American (3), Asian American (3), and Hispanic Ameri-
can (3) ethnicities. DNA and cell lines from 20 of these
individuals was obtained from the Coriell Cell Repositor-
ies for qPCR and MLPA experiments.
Generalized genotyping and candidate CNVs
We used 16 individuals – NA11831, NA12057, NA18505,
NA18507, NA18517, NA18532, NA18545, NA18558,
NA18959, NA18967, NA18969, NA19138, NA19152,
NE00090, NE00403, and NE01119 – as our reference
panel, selected because they are unrelated and are from a
variety of ethnic backgrounds. Using the data from these
16, we trained the PLASQ [12] model parameters as
described. We then used PLASQ to infer the "raw" allele-
specific copy numbers (ASCNs) in our test samples,
restricting our attention to the autosomes. The pairwise
sums of the raw ASCNs yielded raw total copy numbers,
which were rounded to the nearest integer for total copy
numbers. Calls with total copy number deviating from
two provided a preliminary list of aberrant SNPs. These
were converted to the generalized genotypes by assigning
the whole-number portions of the total copy number to
each allele so that the (nearest integer) raw ASCNs were
retained as much as possible. In order to enrich our can-
didate set for true positives, we restricted our attention to
SNPs in runs of at least three independent aberrant SNPs
with aberrations in the same direction (duplication or
deletion). In this context, we consider adjacent SNPs to be
independent only if they reside on different restriction
enzyme fragments, since fragment-specific artifacts arising
during the PCR step of the SNP array protocol [10] would
presumably affect all SNPs on the fragment.
PCR validation of CNVs
Relative gene copy numbers were determined by quantita-
tive real-time PCR using a PRISM 7900HT Sequence
Detection System (384 well) (Applied Biosystems, Foster
City, CA). Real-time PCR was performed in 12.5-μl (384
well) reactions with 2 ng of template DNA. A QuantiTect
SYBR Green PCR kit (Qiagen Inc., Valencia, CA) was used
for the PCR reaction. PCR conditions were as follows: 2
min at 50°C, 15 min at 95°C, followed by 40 three-step
cycles of (20 s at 95°C, 20 s at 58°C, and 30 s at 72°C).
Primers were designed using Primer 3 [33] and synthe-
sized by Integrated DNA Technologies (IDT; Coralville,
IA). Primer sequences are available upon request. Quanti-
fication was based on standard curves from a serial dilu-
tion of human normal genomic DNA. The standard curve
method was used to calculate target DNA copy number in
each DNA sample normalized to a repetitive element
Line-1 and normal reference DNA. For our reference sam-
ple, we used female genomic DNA pools, derived from
multiple anonymous donors (Promega, Madison, WI),
since combining DNA from multiple individuals should
dilute out all but the most common copy number vari-
ants.
MLPA validation of CNVs
Custom MLPA probes were designed to match suitable
sequences within 300 bp of the original SNP location.
Control probes were drawn from other chromosomal
locations and have previously been used to analyze more
than 100 individuals without evidence for copy number
variation [34]. Oligonucleotides were synthesized by IDT,
with 5'-phosphorylation of each downstream probe and
tagged with common PCR primer sequences [14]. Probes
were hybridized with 100 ng aliquots of DNA using MLPA
reagents (part number EK5, MRC-Holland BV, Amster-
dam, The Netherlands) according to the recommended
protocol. Samples were then diluted 10-fold and analyzed
on a 3730xl sequencer with GeneMapper software
(Applied Biosystems). We used male and female genomic
DNA pools, derived from multiple anonymous donors
(Promega, Madison, WI). Furthermore, peak height ratios
were normalized to the mean of the entire data set, rather
than to the controls alone, with subsequent elimination
of outlier samples from the calculation of the mean. Our
experience with well-characterized deletions shows that
this approach gives equivalent results to normalizing
against controls alone, provided that samples with altered
copy number are in the minority (data not shown).
Analysis of SNP alleles in duplications
Determining which SNP alleles are harbored in a duplica-
tion is subject to the same phasing difficulties as SNP hap-
lotype determination. In order to maximize our ability to
determine correct phasing, we considered only SNP sites
that were duplicated to total copy number three in at least
one trio offspring, with one parent having copy number
three and the other either two or three. To avoid the pos-
sibility of a deletion on one chromosome, we omitted
from consideration all loci contained in a deleted regions
in any individual (either in our data or in the Database of
Genomic Variants). This left us with 496 SNPs for which
we sought to detect the presence of the AA, AB, BB, A, and
B chromosomes in our sample set, through a combination
of phasing and examination of individual genotypes (see
Additional data file 4). Note that lack of detection doesBMC Genomics 2007, 8:211 http://www.biomedcentral.com/1471-2164/8/211
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not necessarily indicate absence, but could instead be the
result of ambiguous phase.
Comparison with previously-published CNVs and 
segmental duplications
The previously published CNVs were those catalogued (as
of December 4, 2006) in the Database of Genomic Vari-
ants (Build 35 coordinates). The "rearrangement
hotspots" [16] are regions, between 50 kb and 10 Mb in
length, flanked by segmental duplications at least 10 kb in
length with at least 95% sequence identity. The Build 35
coordinates of these segmental duplications were down-
loaded from the Segmental Duplication Database [35] on
December 4, 2006.
Statistical analysis of GO associations in CNVs
We mapped all SNPs on the array to their genomic posi-
tions using the UCSC Genome Browser (Build 35). The
11,944 genes whose transcribed regions contain at least
one of the (autosomal) SNPs on the array comprised our
"gene universe". Our duplicated genes and deleted genes
were those with transcripts containing SNP sites that were
duplicated or deleted, respectively, in at least one of our
48 samples. We made use of the R [36] software package
GOstats [37] to test our duplicated and deleted genes for
statistical enrichment in certain GO terms (as annotated
by the hgu133plus2 package) [38]. Briefly, for a fixed GO
term, the software performs a Fisher's exact test for the
null hypothesis of no association between duplication or
deletion status and annotation to that term, using all
genes in our gene universe.
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